Sepsis and multiple organ failure after BCG-instillation for bladder cancer

被引:7
作者
Elmer, A
Bermes, U
Drath, L
Büscher, E
Viertel, A
机构
[1] St Josefs Hosp, Med Klin 1, D-65189 Wiesbaden, Germany
[2] St Josefs Hosp, Med Klin 2, D-65189 Wiesbaden, Germany
[3] Urol Praxis, Wiesbaden, Germany
[4] Inst Lab Untersuchungen, Bioscentia, Ingelheim, Germany
来源
INTERNIST | 2004年 / 45卷 / 08期
关键词
hepatitis; sepsis; multiple organ failure; Bacillus Calmette-Guerin; bladder carcinoma;
D O I
10.1007/s00108-004-1205-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Local Bacillus Calmette-Guerin (BCG) immunotherapy is an effective and widely used treatment for superficial bladder carcinoma. Local side effects are frequent, whereas systemic side effects are rare, but more serious. Systemic BCG infection as a life-threatening complication of intravesical BCG instillation should be suspected in any patient who presents with persistent fever after BCG instillation for bladder cancer. A 62-year-old patient had been treated with 6 intravesical BCG instillations for recurrent, multifocal bladder carcinoma. 4 weeks after the last instillation, he presented with fever, malaise and scleral icterus. Laboratory tests revealed abnormal liver function tests, panzytopenia and signs of coagulation disorder. Bone marrow biopsy and liver biopsy showed noncaseating granulomas. Systemic BCG infection was suspected and antituberculous therapy combined with steroids was started. The patient developed severe sepsis and suffered from multiple organ failure. Despite partial improvement, the course was complicated by intracranial sinus thrombosis, and the patient died two month after admission.
引用
收藏
页码:935 / 939
页数:5
相关论文
共 20 条
[1]   A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette-Guerin for bladder cancer - Granulomatous hepatitis due to intravesical instillation of BCG for urinary bladder carcinoma [J].
Barza, MJ ;
Blum, JH ;
Graeme-Cook, FM ;
Basgoz, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :831-837
[2]  
FLIPPIN T, 1980, CANCER-AM CANCER SOC, V46, P1759, DOI 10.1002/1097-0142(19801015)46:8<1759::AID-CNCR2820460810>3.0.CO
[3]  
2-6
[4]  
Göttke MU, 2000, CAN J GASTROENTEROL, V14, P333
[5]  
GRAZIANO DA, 1991, J UROLOGY, V146, P118
[6]   MILIARY TUBERCULOSIS DUE TO INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY [J].
GUPTA, RC ;
LAVENGOOD, R ;
SMITH, JP .
CHEST, 1988, 94 (06) :1296-1298
[7]   BCG immunotherapy:: be cautious of granulomas -: Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations [J].
Kamphuis, JT ;
Buiting, AGM ;
Miseré, JFMM ;
Henegouwen, DPV ;
van Soolingen, D ;
Rensma, PL .
NETHERLANDS JOURNAL OF MEDICINE, 2001, 58 (02) :71-75
[8]   INCIDENCE AND TREATMENT OF COMPLICATIONS OF BACILLUS-CALMETTE-GUERIN INTRAVESICAL THERAPY IN SUPERFICIAL BLADDER-CANCER [J].
LAMM, DL ;
VANDERMEIJDEN, APM ;
MORALES, A ;
BROSMAN, SA ;
CATALONA, WJ ;
HERR, HW ;
SOLOWAY, MS ;
STEG, A ;
DEBRUYNE, FMJ .
JOURNAL OF UROLOGY, 1992, 147 (03) :596-600
[9]   COMPLICATIONS OF BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY IN 1,278 PATIENTS WITH BLADDER-CANCER [J].
LAMM, DL ;
STOGDILL, VD ;
STOGDILL, BJ ;
CRISPEN, RG .
JOURNAL OF UROLOGY, 1986, 135 (02) :272-274
[10]  
LAMM DL, 1992, UROL CLIN N AM, V19, P565